Table 1 Patient characteristics
All patients (n = 182) | |
|---|---|
Demographic parameters | |
Age, years, mean (SD) | 54.2 (11.8) |
Female sex, n (%) | 135 (75) |
Disease parameters | |
Disease duration in years, mean (SD) | 9.7 (10.3) |
DAS28, mean (SD) | 5.1 (1.2) |
Erosive disease, n (%) | 131 (72) |
Nodules, n (%)a | 43 (24) |
Laboratory parameters | |
ESR, mm/h, mean (SD) | 24.5 (18.0) |
CRP, mg/L, mean (SD) | 17.8 (22.1) |
IgM-RF titer, IU/ml, mean (SD)b | 124.7 (279) |
IgM-RF-positive, n (%)b | 95 (59) |
ACPA titer, AU/ml, mean (SD)c | 1563 (2680) |
ACPA-positive, n (%)c | 131 (75) |
IFN score, mean (SD) | 0.26 (1.01) |
Medication parameters | |
MTX use, n (%) | 152 (84) |
MTX dosage in mg/week, mean (SD) | 21.0 (6.3) |
Prednisone use, n (%) | 52 (29) |
Prednisone dosage in mg/day, mean (SD) | 7.2 (3.5) |
HCQ use, n (%) | 35 (19) |
SSZ use, n (%) | 27 (15) |